Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) announced preclinical safety data for Nu-3, a gel formulation targeting the topical treatment of infected ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA